41 results on '"Wu, Eric Q."'
Search Results
2. Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations
3. Health care resource utilization and cost burden of hemophilia B in the United States
4. Postdischarge Health Care Costs and Readmission in Patients With Hyperkalemia-Related Hospitalizations
5. The Development of Health Technology Assessment in Asia: Current Status and Future Trends
6. Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration
7. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator
8. Cost Effectiveness Analysis of Tisagenlecleucel for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma in Japan
9. Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia in Japan
10. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis
11. Effectiveness of Everolimus Versus Endocrine Monotherapy or Chemotherapy Among HR+/HER2− mBC Patients With Multiple Metastatic Sites
12. Association of early suspected acute exacerbations of idiopathic pulmonary fibrosis with subsequent clinical outcomes and healthcare resource utilization
13. Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United States
14. ALK rearrangement testing and treatment patterns for patients with ALK-positive non-small cell lung cancer
15. Effect of Adherence and Insulin Delivery System on Clinical and Economic Outcomes among Patients with Type 2 Diabetes Initiating Insulin Treatment
16. Impact of Timely Switching From Imatinib to a Second-Generation Tyrosine Kinase Inhibitor After 12-Month Complete Cytogenetic Response Failure: A Chart Review Analysis
17. Development and validation of a claims-based prediction model for COPD severity
18. Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
19. Cost-Effectiveness of Denosumab Compared With Zoledronic Acid in Patients With Breast Cancer and Bone Metastases
20. Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD
21. Comparison of Skeletal Complications and Treatment Patterns Associated With Early vs. Delayed Zoledronic Acid Therapy in Multiple Myeloma
22. Inhaled corticosteroids or long-acting β-agonists alone or in fixed-dose combinations in asthma treatment: A systematic review of fluticasone/budesonide and formoterol/salmeterol
23. Productivity Costs Associated with Cardiometabolic Risk Factor Clusters in the United States
24. Mapping FACT-P and EORTC QLQ-C30 to Patient Health Status Measured by EQ-5D in Metastatic Hormone-Refractory Prostate Cancer Patients
25. Cost-Effectiveness of Duloxetine Versus Routine Treatment for U.S. Patients With Diabetic Peripheral Neuropathic Pain
26. Estimation of Total Costs in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Receiving Tisagenlecleucel from a US Hospital's Perspective
27. Treatment Patterns and Outcomes in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A SEER-Medicare Analysis
28. Estimation of Total Costs in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Receiving Tisagenlecleucel from a US Hospital's Perspective
29. Five-Year Direct Cost of Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) Undergoing Allogeneic Stem Cell Transplantation (HSCT): An Analysis from US Payers' Perspective
30. Economic Consequences of Cytomegalovirus Disease Among Stem Cell Transplant Recipients
31. Comparison of Real-World Treatment Patterns and Clinical Outcomes in 18-59 Year-Old Patients with FLT3 Mutated Vs. FLT3 Wild Type Acute Myeloid Leukemia: A Medical Records Review
32. Comparison of Survival Rates, Healthcare Resource Use and Costs of Elderly Patients with Chronic Myeloid Leukemia Receiving Dasatinib or Nilotinib As Second-Line Therapy
33. Approach to Fixing the Discrepancy Found in the Wu et al. FACT-P to EQ5D Mapping Algorithm—Reply to Letter to the Editor by David Cella, Irina Proskorovsky, and Feng Pan
34. Su1194 Treatment Patterns and Indicators of Unmet Needs in Medicaid Patients With Irritable Bowel Syndrome With Constipation and Chronic Constipation
35. EVALUATION OF INTERNATIONAL NORMALIZED RATIO MONITORING AND ANTICOAGULATION CONTROL IN ATRIAL FIBRILLATION/FLUTTER PATIENTS USING WARFARIN AND ANTIARRHYTHMIC DRUG THERAPY
36. Resource Utilization and Costs in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Multiple vs Single Long-Acting Inhalers
37. Persistence and Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Multiple vs Single Long-Acting Inhalers
38. Risk of Exacerbations Among Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Multiple vs Single Long-Acting Inhalers
39. M1047 Quality-of-Life Benefits for Adalimumab-Treated Patients With Moderate to Severe Crohn's Disease are Predicted by Early Mucosal Healing Status
40. 644 Early Mucosal Healing Status Predicts Long-Term Clinical Benefits for Adalimumab-Treated Patients With Moderate to Severe Crohn's Disease
41. Author reply
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.